Abu Dhabi and Sanofi Plan AI Vaccine Innovation Center

The future of vaccine development just got brighter in the Middle East.

Abu Dhabi's Department of Health and Sanofi signed an agreement to jointly explore creating a Vaccine Innovation Centre that would combine artificial intelligence, mRNA research, and advanced manufacturing under one roof. The partnership was announced at the BIO International Convention 2026 in San Diego, where leaders from both organizations formalized their commitment.

The planned center would operate within Abu Dhabi's Health, Endurance, Longevity, and Medicine (HELM) Cluster, bringing together scientists, researchers, clinical experts, and manufacturers in a single ecosystem. This approach is designed to speed up the journey from initial discovery to getting vaccines into arms around the world.

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health Abu Dhabi, emphasized how the collaboration connects crucial capabilities. "We are bringing together AI, scientific research, clinical expertise, advanced manufacturing and enabling regulation within a single ecosystem designed to accelerate the journey from discovery to impact," she explained.

The center would focus on AI-enabled vaccine discovery, a technology that can analyze millions of data points to identify promising vaccine candidates faster than traditional methods. It would also advance mRNA research, the same technology that enabled rapid COVID-19 vaccine development and holds promise for treating everything from cancer to rare diseases.

Sanofi's Baptiste de Clarens highlighted how innovation is transforming vaccine development. "Vaccine innovation today is being reshaped by artificial intelligence, by advances in mRNA science, and by new models that connect discovery, development and manufacturing," he said.

Beyond developing new vaccines, the center aims to strengthen global health security by improving preparedness for future health challenges. It would also help expand access to advanced vaccines in regions that currently have limited availability.

The Ripple Effect

This partnership represents more than just one research facility. Abu Dhabi is investing in building local scientific talent, creating jobs for researchers, technicians, and healthcare professionals in cutting-edge fields. The center could train the next generation of vaccine scientists while contributing solutions that benefit communities worldwide.

The collaboration also positions the region as a meaningful contributor to global health innovation rather than just a consumer of medical advances developed elsewhere. By combining Abu Dhabi's infrastructure and investment capacity with Sanofi's decades of vaccine expertise, the partnership creates opportunities for breakthroughs that might not happen in isolation.

A single ecosystem connecting research, clinical trials, manufacturing, and healthcare delivery could dramatically shorten the time from discovering a vaccine candidate to reaching patients who need it.